Reviva Pharmaceuticals Holdings, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $3.9M | $25.3M | $23.4M |
| Jun 2022 | $4.6M | $20.6M | $19.4M |
| Sep 2022 | $6.5M | $24.0M | $23.2M |
| Dec 2022 | $10.5M | $18.9M | $18.5M |
| Mar 2023 | $11.3M | $12.9M | $11.3M |
| Jun 2023 | $13.7M | $11.8M | $11.2M |
| Sep 2023 | $18.2M | $5.4M | $5.0M |
| Dec 2023 | $18.0M | $23.7M | $23.4M |
| Mar 2024 | $14.8M | $13.5M | $12.0M |
| Jun 2024 | $14.1M | $8.1M | $6.2M |
| Sep 2024 | $17.6M | $7.6M | $5.6M |
| Dec 2024 | $14.7M | $15.5M | $13.5M |
| Mar 2025 | $11.5M | $7.1M | $5.3M |
| Jun 2025 | $12.1M | $11.6M | $10.4M |
| Sep 2025 | $9.8M | $14.3M | $13.2M |
| Dec 2025 | $7.3M | $15.9M | $14.4M |
| Mar 2026 | $6.1M | $23.6M | $22.2M |
| Jun 2026 | $5.9M | $21.1M | $19.9M |